MyAverix Finance
US · Healthcare
Ayurcann Holdings Corp (AYURF)
Drug Manufacturers - Specialty & Generic
Ayurcann Holdings Corp (AYURF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for AYURF
Ayurcann Holdings Corp (AYURF) — FAQ
What is AYURF's P/E ratio?
The price-to-earnings (P/E) ratio for Ayurcann Holdings Corp (AYURF) is 18.00 (data as of 2026-03-23).
Does Ayurcann Holdings Corp pay a dividend?
Dividend yield is not available in the current snapshot for Ayurcann Holdings Corp (AYURF). Check the MyAverix Finance app for the latest dividend data.
What sector is Ayurcann Holdings Corp in?
Ayurcann Holdings Corp (AYURF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is AYURF listed on?
AYURF is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.